We develop the drug candidate BAFA

We develop the
drug candidate BAFA
Drug candidate BAFA
Demand and market
About Epicyt Pharma
Investors
News
- Search Epicyt Pharma
  Search for:
Contact information
Epicyt Pharma AB
Visiting and postal address:
c/o Business Control Partner Norden AB
Krokslätts Fabriker 30, SE-431 37 Mölndal, Sweden
invoice@epicytpharma.com
Epicyt Pharma AB is a Gothenburg-based pharmaceutical R&D company whose development effort is focused on calcium absorption in the intestine and how this affects the bone health. The company was founded in 2014 when the scientist Lars Fändriks and Ville Wallenius together with a group of investors decided to exploit the discovery.

Company news

News
- Company news
- Press releases

All News | Company news | Press releases

Company news will be published here

6 September, 2026

CONTACT

Epicyt Pharma AB
Visiting and postal address:
c/o Business Control Partner Norden AB
Krokslätts Fabriker 30, SE-431 37 Mölndal, Sweden

invoice@epicytpharma.com

ABOUT

Epicyt Pharma AB is a Gothenburg-based pharmaceutical R&D company whose development effort is focused on intestinal calcium absorption and how this affects the bone health. The company was founded in 2016 when Lars Fändriks (MD, PhD and Professor in integrative physiology at the Sahlgrenska Academy) and Ville Wallenius (MD, PhD and Associate Professor at the Sahlgrenska Academy) together with a group of investors decided to exploit their discovery research.

BAFA

BAFA, with the active substances glycocholate (a bile acid) and butyrate (a fatty acid), is intended for the treatment of decreased calcium absorption after RYGB surgery. Research shows that patients have an 80% reduced absorption of calcium already one year post surgery. Read more >>

Manage consent

To provide the best experience, we use technologies such as cookies to store and/or access device information. Consenting to these technologies allows us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may negatively affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Alternativ Alternativ

Den tekniska lagringen eller åtkomsten är nödvändig för det legitima syftet att lagra inställningar som inte efterfrågas av abonnenten eller användaren.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. Den tekniska lagringen eller åtkomsten som används uteslutande för anonyma statistiska ändamål. Utan en stämningsansökan, frivillig efterlevnad från din Internetleverantörs sida, eller ytterligare register från en tredje part, kan information som lagras eller hämtas endast för detta ändamål vanligtvis inte användas för att identifiera dig.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across multiple websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Search Epicyt Pharma

Contact information

Company news will be published here